Mesenchymal stem cell therapy for intractable neonatal disorders
Mesenchymal stem cell (MSC) transplantation has emerged as a new promising therapeutic strategy for the treatment of intractable and devastating neonatal disorders with complex multifactorial etiologies, including bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and hypoxic-ische...
Main Authors: | So Yoon Ahn, Won Soon Park, Se In Sung, Yun Sil Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957220301984 |
Similar Items
-
Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton’s Jelly–Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy
by: Young Eun Kim, et al.
Published: (2019-05-01) -
Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
by: So Yoon Ahn, et al.
Published: (2021-08-01) -
Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage
by: So Yoon Ahn, et al.
Published: (2014-06-01) -
Thrombin Preconditioning of Extracellular Vesicles Derived from Mesenchymal Stem Cells Accelerates Cutaneous Wound Healing by Boosting Their Biogenesis and Enriching Cargo Content
by: Dong Kyung Sung, et al.
Published: (2019-04-01) -
Mesenchymal stem cell and hematopoietic stem cell transplantation for vasculitis
by: Lianming Liao
Published: (2020-01-01)